Is Microneedling With Exosomes Safe? Risks, Side Effects & FDA Status

At Azani Medical Spa in Bethlehem, PA, patients considering emerging treatments such as microneedling with exosomes deserve more than a list of potential benefits—they deserve a clear explanation of what is known about safety, what remains uncertain, and what the FDA has actually reviewed. Microneedling itself has an established safety profile when performed appropriately, but combining microneedling with an exosome-containing product introduces additional regulatory and scientific questions that are not answered simply by the safety profile of microneedling alone.

The short answer is:

Microneedling can be performed safely in appropriately selected patients by trained professionals, but the long-term safety of microneedling combined with exosome products has not been established.

That distinction is important.

A 2026 systematic review of microneedling with exosomes identified 256 unique references but ultimately included only eight studies in its final narrative synthesis. Study sizes ranged from just 3 to 60 participants, and the authors concluded that larger studies with longer follow-up are needed to determine the treatment’s long-term safety and effectiveness.

The FDA also makes an important distinction: certain microneedling devices have FDA marketing authorization for specific uses, but the FDA has not cleared microneedling devices for use with another product, meaning the safety and effectiveness of combining a device with an exosome preparation have not been reviewed by the agency.

At a Glance

What Makes Microneedling a Medical Procedure?

Microneedling involves creating controlled micro-injuries in the skin with multiple small needles. Depending on the device and treatment depth, the needles can penetrate living layers of skin containing:

• Blood vessels
• Nerves
• Connective tissue
• Inflammatory cells
• Fibroblasts

The intended response is controlled wound healing and remodeling.

Because the skin barrier is intentionally disrupted, however, microneedling is not risk-free.

The FDA notes that microneedling devices can cause both short-term and longer-lasting adverse effects. Common risks include dryness, roughness, tightness, redness, itching, peeling, discomfort, burning, bruising, bleeding and crusting. Less common risks include infection, pigmentation changes, herpes reactivation and other complications.

That is why appropriate patient selection, device selection, sterile technique and aftercare matter.

What Happens When Exosomes Are Added?

The safety question becomes more complicated when an exosome-containing product is introduced.

The rationale behind combining the two treatments is that microneedling creates controlled microchannels and exosome-containing preparations may provide biological signaling molecules during the skin-repair process.

But this combination raises an important question:

What happens when a product that has not been FDA-approved is applied to or potentially introduced into skin that has just been mechanically disrupted?

There is not enough high-quality evidence to answer that question comprehensively for all exosome products.

Different preparations may differ in:

• Biological source
• Manufacturing process
• Purification
• Concentration
• Formulation
• Storage
• Sterility
• Characterization
• Contaminants or impurities
• Route of administration

Consequently, the safety findings from one study cannot automatically be applied to every product marketed as an “exosome” treatment.

The 2026 clinical literature specifically highlights substantial heterogeneity among exosome preparations and treatment protocols.

What Are the Common Side Effects of Microneedling?

Most expected microneedling reactions are temporary.

These may include:

Redness

The skin commonly becomes red immediately after treatment because of controlled inflammation and increased blood flow.

Swelling

Mild edema can occur, particularly when treatment is more intensive.

Tightness

Patients may describe the skin as feeling tight or stretched for several days.

Dryness and peeling

The treated skin may become dry or flaky during the healing process.

Sensitivity

Skin may temporarily become more sensitive to:

• sunlight
• skincare products
• heat
• friction

Mild bleeding

Pinpoint bleeding may occur depending on treatment depth.

Bruising

Small areas of bruising can occur in some patients.

The FDA identifies these reactions among the known risks of authorized microneedling uses.

Can Microneedling Cause Infection?

Yes.

Any procedure that penetrates the skin creates a potential route for microorganisms to enter.

The risk depends heavily on:

• device cleanliness
• cartridge sterility
• preparation of the treatment area
• provider technique
• post-treatment care
• whether equipment is reused

The FDA specifically recommends that a new microneedle cartridge be used for every patient and every treatment session, and warns that reusing cartridges can cause transmission of infectious agents.

Patients should feel comfortable asking:

“Is a new cartridge being used for my treatment?”

That is a reasonable and important safety question.

Can Microneedling Cause Hyperpigmentation?

Yes.

Pigmentation changes are among the recognized less-common risks of microneedling.

These can include:

• hyperpigmentation
• hypopigmentation

The risk deserves particular attention in patients who are prone to post-inflammatory pigmentation. This is one reason treatment intensity should be individualized rather than assuming that deeper or more aggressive treatment is automatically better.

Patients should also be particularly careful about sun exposure around treatment because recently treated skin may be more sensitive.

The FDA specifically notes that patients with darker skin types may have a risk of darkening or lightening after microneedling and that some authorized devices were not studied extensively in darker skin types.

Can Exosomes Cause Side Effects?

Potentially, yes.

One of the problems with discussing “exosome safety” as if exosomes were a single standardized medication is that they are not one standardized product. An exosome preparation can vary according to its source and manufacturing process.

Potential concerns include:

• Contamination
• Immune or inflammatory reactions
• Inappropriate biological activity
• Impurities
• Product instability
• Inadequate characterization
• Inappropriate storage
• Sterility problems

The route of administration also matters. Topical application after microneedling is not equivalent to injecting an exosome-containing product into the skin.

Why Exosome Injections Are a Different Safety Question

There have been reports of serious adverse reactions following intradermal injection of unapproved exosome-containing products.

A 2025 case series described four women who developed persistent erythema, nodules, granulomatous inflammation and scarring after intradermal administration of unregulated exosome-based formulations. Some required corticosteroids, laser treatment or surgical removal, and all had incomplete resolution with residual scarring.

These cases involved injection, not conventional topical application after microneedling.

That distinction is crucial. They should not be used to claim that topical exosome-assisted microneedling causes the same complications. But they do demonstrate why patients should not assume that every product marketed as an “exosome treatment” has an established safety profile.

What Does Clinical Research Say About Safety?

The early clinical literature is somewhat reassuring—but not sufficient to establish long-term safety.

A retrospective study of 40 patients receiving an exosome-containing skin booster with microneedling reported that adverse events were mild and transient, with no serious adverse reactions during the study’s eight-week follow-up period.

A 2025 split-face observational study involving nine women undergoing energy-based treatments with and without exosomes reported no serious adverse events during six months of follow-up.

Another study involving microneedling combined with an exosome preparation for facial pores and skin texture reported no adverse events through 22 weeks of follow-up.

These results are encouraging.

But there is an important limitation:

A study reporting no serious adverse events does not prove that a treatment has no serious risks.

Small studies may simply be unable to detect uncommon complications. And short follow-up cannot establish long-term safety. That is precisely why the 2026 systematic review concluded that larger studies with longer follow-up are necessary.

What Are the Biggest Safety Questions With Exosomes?

For patients, the most useful safety questions are often not simply:

“Are exosomes safe?”

Instead, ask:

1. What exactly is the product?

The word “exosome” alone does not adequately identify a preparation.

2. Where does it come from?

Exosome-containing products may be derived from different biological sources.

3. How was it manufactured?

Processing and purification can affect the final product.

4. How is sterility maintained?

This is especially important when the skin barrier is intentionally disrupted.

5. How is the product stored?

Storage conditions can affect biological products.

6. What clinical evidence exists for this specific preparation?

Evidence for one product should not automatically be extrapolated to another.

7. Is it being applied topically or injected?

These are fundamentally different routes.

8. What has FDA actually reviewed?

“FDA registered,” “FDA compliant,” “manufactured in an FDA-registered facility” or similar language does not mean that an exosome product is FDA-approved.

Are Exosome Products FDA-Approved?

No.

This is one of the most important facts in this entire topic.

The FDA states:

There are currently no FDA-approved exosome products.

FDA also explains that exosome products intended to treat diseases or conditions in humans generally require FDA approval. Therefore, patients should be cautious when they encounter advertisements describing an exosome product as:

• FDA-approved
• FDA-cleared
• FDA-authorized
• FDA-certified

unless the specific claim can be independently verified.

What About FDA-Authorized Microneedling Devices?

This is different. The FDA has legally authorized certain microneedling devices for specific uses. Current FDA information states that certain devices have marketing authorization for uses including improving the appearance of:

• Facial acne scars
• Facial wrinkles
• Abdominal scars in adults 22 years and older

But those authorizations are device- and indication-specific. That does not mean that every microneedling treatment is FDA-authorized. And it does not mean that the FDA has approved the combination of microneedling with an exosome product.

Has FDA Cleared Microneedling With Exosomes?

No. The FDA specifically states that microneedling devices have not been cleared for use with another product.

That includes combinations involving:

• Cosmetics
• Topical medications
• Drugs
• Biologics
• PRP
• Other products

The FDA explains that when a microneedling device is used with another product, the agency has not reviewed the safety or effectiveness of that combination.

Therefore:

FDA authorization of a microneedling device does not equal FDA approval of microneedling with exosomes.

What About RF Microneedling?

RF microneedling deserves its own discussion because it is not simply conventional microneedling. RF microneedling uses needles or electrodes to deliver radiofrequency energy into tissue, creating heat at selected depths. That additional energy changes the risk profile.

In October 2025, the FDA issued a safety communication warning about serious complications reported with certain uses of RF microneedling.

Reported complications included:

• Burns
• Scarring
• Fat loss
• Disfigurement
• Nerve damage

Some injuries required medical or surgical intervention.

This does not mean that every RF microneedling treatment causes these complications.

It means that patients should recognize that RF microneedling is a medical procedure with risks that are different from those of conventional microneedling.

The FDA recommends seeking a licensed healthcare provider with appropriate training and experience for RF microneedling and specifically states that these devices should not be used at home.

Is Conventional Microneedling Safer Than RF Microneedling?

It is not appropriate to make a blanket statement that one is universally “safer.”

They are different technologies. Conventional microneedling primarily produces controlled mechanical micro-injury. RF microneedling combines mechanical penetration with thermal energy.

The appropriate choice depends on:

• The patient’s goals
• Anatomy
• Skin characteristics
• Treatment area
• Device
• Treatment settings
• Provider training
• Risk tolerance

For some patients, conventional microneedling may be sufficient without introducing additional thermal energy.

Who May Not Be a Good Candidate for Microneedling?

Microneedling is not appropriate for everyone.

According to FDA information, patients may need to avoid or postpone treatment in situations including:

• Active skin infection
• Active facial rash
• Active cold sores
• Certain bleeding or clotting disorders
• Immune deficiency or immunosuppression
• Uncontrolled diabetes
• Certain autoimmune or inflammatory skin conditions
• Current or recent isotretinoin use
• A history of keloid scarring
• Certain lesions or abnormalities in the treatment area
• Pregnancy or breastfeeding
• Known allergies to relevant materials or anesthetics

The FDA also advises caution in patients with darker skin types because pigmentary changes can occur. This does not mean that every patient with one of these characteristics is automatically excluded.

It means that candidacy should be determined individually.

What Should You Do Before Treatment?

A safe consultation should cover more than just treatment goals.

Important topics include:

Your medical history

Tell the provider about relevant medical conditions, medications and allergies.

Your skin history

Discuss:

• Acne
• Eczema
• Psoriasis
• Cold sores
• Keloids
• Pigmentation problems
• Prior procedures

Your medications

Some medications can affect bleeding, healing or skin sensitivity.

Your history of herpes simplex

Patients with recurrent cold sores may need individualized preventive planning.

Your recent sun exposure

Recently tanned or sun-damaged skin may not be appropriate for treatment.

Your expectations

The goal should be realistic improvement rather than guaranteed perfection.

What Should You Do After Treatment?

Post-treatment instructions should be individualized, but generally patients should expect their skin to be more sensitive immediately after microneedling.

Important considerations include:

• Following the provider’s skincare instructions
• Avoiding unnecessary irritation
• Protecting the skin from sunlight
• Avoiding picking or scratching treated skin
• Using only recommended products
• Contacting the provider if unexpected symptoms develop

The FDA notes that skin can be more sensitive to sunlight and to certain skincare ingredients following microneedling.

When Should You Contact Your Provider?

Expected mild redness and sensitivity generally improve as the skin heals.

Contact your provider promptly if you develop symptoms that are:

• Severe
• Worsening rather than improving
• Unexpectedly painful
• Associated with significant swelling
• Associated with pus or drainage
• Accompanied by fever
• Associated with blistering or extensive burns
• Associated with persistent nodules or unusual inflammatory reactions

After RF microneedling, unexpected burns, significant pain, tissue changes or other concerning symptoms warrant medical evaluation.

How Can Patients Reduce Their Risk?

The most important safety measures are relatively straightforward.

Choose an appropriately trained provider

The FDA recommends selecting a healthcare provider who has appropriate training and experience with microneedling.

Confirm that an appropriate device is being used

Patients can ask which device is being used and what it is authorized for.

Ask about cartridge replacement

A new cartridge should be used for every patient and treatment session.

Ask about infection control

Equipment should be cleaned and disinfected according to manufacturer instructions.

Understand what product is being used

If an exosome-containing product is part of the treatment, ask about its source, handling and evidence.

Understand what the FDA has—and has not—reviewed

This is particularly important for emerging treatments.

Avoid assuming that “natural” means safe

Biological products can have biological effects, and those effects are not necessarily predictable from the word “natural.”

Is Microneedling With Exosomes Safer Than Other Cosmetic Procedures?

There is currently not enough evidence to make that claim.

Comparing safety across aesthetic procedures requires standardized studies measuring:

• The same patient populations
• The same outcomes
• The same follow-up duration
• Similar treatment intensity
• Standardized definitions of adverse events

The existing exosome literature does not yet provide that level of evidence.

The 2026 systematic review specifically concluded that the evidence remains insufficient to establish the long-term safety profile of combined microneedling and exosome treatment.

What Does “Promising” Actually Mean?

“Promising” is a useful word—but it is sometimes misunderstood.

When researchers describe exosome treatments as promising, they generally mean that early observations suggest the treatment deserves further investigation.

It does not mean:

• Proven
• Risk-free
• FDA-approved
• Superior to established treatments
• Appropriate for everyone
• Effective with every exosome product

That distinction is especially important in aesthetic medicine, where marketing language can move faster than clinical evidence.

What Questions Should You Ask Before Treatment?

Before undergoing microneedling with exosomes, consider asking:

1. What exact product will be used?
2. What is the source of the exosome preparation?
3. Is the product intended for topical use or injection?
4. How is the product manufactured and stored?
5. What clinical studies support this particular product or protocol?
6. Has the FDA reviewed the product?
7. What is the FDA authorization for the microneedling device?
8. Will a new sterile cartridge be used for my treatment?
9. What are the risks for my particular skin type?
10. What alternatives are available?
11. What should I expect during recovery?
12. What symptoms should prompt me to contact the provider?

A provider who takes safety seriously should be willing to answer these questions clearly.

Meet Dr. Monica Gavin, MD

Dr. Monica Gavin, MD, MBA, is the physician, Medical Director and owner of Azani Medical Spa in Bethlehem, Pennsylvania. Her practice combines medical oversight with aesthetic, anti-aging and wellness care, with an emphasis on individualized treatment planning and patient education.

For emerging aesthetic technologies such as exosome-based treatments, that physician-led approach is particularly important. Patients should understand both the potential benefits and the limitations of the available evidence before deciding whether a treatment is appropriate.

Dr. Gavin’s approach emphasizes informed decision-making rather than assuming that a newer treatment is automatically a better treatment.

The Bottom Line

Is microneedling with exosomes safe?

The most accurate answer is:

Microneedling itself has a recognized safety profile when performed appropriately, but the long-term safety of combining microneedling with exosome products has not been established.

Early studies of topical exosome-assisted microneedling have generally reported mild, transient adverse effects, and several small studies have reported no serious adverse events during relatively short follow-up periods.

But the evidence remains limited.

A 2026 systematic review found only eight studies suitable for its final synthesis and concluded that larger studies and longer follow-up are necessary to establish the efficacy and safety profile of the treatment.

Meanwhile, FDA states that:

• There are currently no FDA-approved exosome products
• Microneedling devices have authorization only for specific uses
• Microneedling devices have not been cleared for use with another product
• RF microneedling carries additional risks and has been the subject of an FDA safety communication

For patients considering this treatment, the safest approach is not to ask simply whether “exosomes are safe.”

Ask instead:

What product is being used, how is it being used, what evidence supports it, what has the FDA reviewed, and is this treatment appropriate for me?

Those are the questions that turn an emerging aesthetic treatment from a marketing claim into an informed medical decision.

Considering Microneedling With Exosomes?

If you’re considering microneedling with exosomes, a personalized consultation can help determine whether it is appropriate for your skin, goals and medical history—and whether another evidence-supported treatment may be a better option.

Azani Medical Spa
2551 Baglyos Circle A18
Bethlehem, PA 18020
610-625-3000

Medical Disclaimer

This article is intended for educational purposes only and does not constitute medical advice, diagnosis or treatment. Microneedling and exosome-related treatments may not be appropriate for every patient. Individual risks depend on medical history, skin characteristics, the device and treatment protocol, and the specific product used. Patients should discuss potential benefits, risks, alternatives and regulatory status with a qualified healthcare professional.

Last medically reviewed and updated: September 8, 2026